Marion Sassier

1.5k total citations · 1 hit paper
38 papers, 1.0k citations indexed

About

Marion Sassier is a scholar working on Oncology, Pharmacology and Toxicology. According to data from OpenAlex, Marion Sassier has authored 38 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Pharmacology and 9 papers in Toxicology. Recurrent topics in Marion Sassier's work include Pharmacovigilance and Adverse Drug Reactions (9 papers), Drug-Induced Adverse Reactions (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Marion Sassier is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (9 papers), Drug-Induced Adverse Reactions (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Marion Sassier collaborates with scholars based in France, United States and New Zealand. Marion Sassier's co-authors include Joachim Alexandre, Charles Dolladille, Anne‐Flore Plane, Sophie Fédrizzi, Damien Legallois, Basile Chrétien, Angélique Da Silva, Véronique Lelong‐Boulouard, Stéphane Éderhy and Franck Thuny and has published in prestigious journals such as Annals of Neurology, Scientific Reports and American Journal of Epidemiology.

In The Last Decade

Marion Sassier

36 papers receiving 989 citations

Hit Papers

Immune Checkpoint Inhibitor Rechallenge After Immune-Rela... 2020 2026 2022 2024 2020 100 200 300

Peers

Marion Sassier
Melissa Moey United States
Marion Sassier
Citations per year, relative to Marion Sassier Marion Sassier (= 1×) peers Melissa Moey

Countries citing papers authored by Marion Sassier

Since Specialization
Citations

This map shows the geographic impact of Marion Sassier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marion Sassier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marion Sassier more than expected).

Fields of papers citing papers by Marion Sassier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marion Sassier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marion Sassier. The network helps show where Marion Sassier may publish in the future.

Co-authorship network of co-authors of Marion Sassier

This figure shows the co-authorship network connecting the top 25 collaborators of Marion Sassier. A scholar is included among the top collaborators of Marion Sassier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marion Sassier. Marion Sassier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chrétien, Basile, Marion Sassier, Melissa St. Pierre, et al.. (2024). Association between antidepressant use and delirium in older adults: an analysis of the World Health Organization’s global pharmacovigilance database. BMC Geriatrics. 24(1). 600–600. 4 indexed citations
2.
Morice, Pierre‐Marie, Marion Sassier, Véronique Lelong‐Boulouard, et al.. (2024). Acute lymphoblastic leukemia in patients treated with lenalidomide for multiple myeloma: a safety meta-analysis of randomized controlled trials combined with a retrospective study of the WHO’s pharmacovigilance database. Blood Cancer Journal. 14(1). 177–177. 1 indexed citations
3.
Alexandre, Joachim, Pierre‐Marie Morice, Marion Sassier, et al.. (2023). Atrial Fibrillation Incidence Associated With Exposure to Anticancer Drugs Used as Monotherapy in Clinical Trials. JACC CardioOncology. 5(2). 216–226. 10 indexed citations
4.
Chrétien, Basile, Perrine Brazo, Angélique Da Silva, et al.. (2023). Infections associated with clozapine: a pharmacovigilance study using VigiBase®. Frontiers in Pharmacology. 14. 1260915–1260915. 5 indexed citations
5.
Roule, Vincent, Joachim Alexandre, Adrien Lemaître, et al.. (2023). Rhabdomyolysis with Co-Administration of Statins and Antiplatelet Therapies—Analysis of the WHO Pharmacovigilance Database. Cardiovascular Drugs and Therapy. 38(6). 1191–1199. 9 indexed citations
6.
Dolladille, Charles, Basile Chrétien, Marion Sassier, et al.. (2021). Antidépresseurs et hypertension artérielle : étude cas /non-cas dans la base nationale de pharmacovigilance. L Encéphale. 48(4). 404–408. 1 indexed citations
8.
Chrétien, Basile, Véronique Lelong‐Boulouard, Sylvain Chantepie, et al.. (2020). Haematologic malignancies associated with clozapine v. all other antipsychotic agents: a pharmacovigilance study in VigiBase®. Psychological Medicine. 51(9). 1459–1466. 27 indexed citations
9.
Dolladille, Charles, Théodora Bejan‐Angoulvant, Khalil Zaman, et al.. (2020). Cardiovascular safety of rapidly accelerated fibrosarcoma B-type and/or mitogen-activated extracellular signal-regulated kinase inhibitors: A mixed approach combining a meta-analysis and a pharmacovigilance disproportionality analysis. Archives of cardiovascular diseases. 113(6-7). 420–432. 5 indexed citations
10.
Scailteux, Lucie‐Marie, Clémence Lacroix, Fabien Despas, et al.. (2020). Profils d’effets indésirables sous abiratérone et enzalutamide : analyse descriptive des données de la base nationale de pharmacovigilance. Therapies. 76(5). 455–465. 4 indexed citations
11.
Dolladille, Charles, Marion Sassier, Véronique Lelong‐Boulouard, et al.. (2020). Clinically significant drug-drug interactions between tramadol and CYP3A4 inhibitors: disproportionality analysis in VigiBase® and hypothesis on the underlying mechanism. European Journal of Clinical Pharmacology. 76(7). 1049–1051. 4 indexed citations
12.
Alexandre, Joachim, Joe‐Elie Salem, Javid J. Moslehi, et al.. (2020). Identification of anticancer drugs associated with atrial fibrillation: analysis of the WHO pharmacovigilance database. European Heart Journal - Cardiovascular Pharmacotherapy. 7(4). 312–320. 42 indexed citations
13.
Petitpain, Nadine, Franck Rouby, Marion Sassier, et al.. (2019). Immune check point inhibitors-induced hypophysitis: a retrospective analysis of the French Pharmacovigilance database. Scientific Reports. 9(1). 19419–19419. 52 indexed citations
14.
Dolladille, Charles, Xavier Humbert, Marion Sassier, et al.. (2018). Association between venous thromboembolism events and fibrates: A comparative study. Therapies. 74(3). 421–430. 3 indexed citations
15.
Gauci, Marie-Léa, Philippe Boudou, Barouyr Baroudjian, et al.. (2018). Occurrence of type 1 and type 2 diabetes in patients treated with immunotherapy (anti-PD-1 and/or anti-CTLA-4) for metastatic melanoma: a retrospective study. Cancer Immunology Immunotherapy. 67(8). 1197–1208. 26 indexed citations
16.
Humbert, Xavier, Charles Dolladille, Marion Sassier, et al.. (2017). Fibrates et risques thrombo-emboliques veineux : étude cas/non-cas dans la base nationale de pharmacovigilance. Therapies. 72(6). 677–682. 4 indexed citations
17.
Lanot, Antoine, et al.. (2017). Acidose à la 5-oxoproline induite par le paracétamol : une cause rare d’acidose métabolique à trou anionique augmenté. La Revue de Médecine Interne. 39(2). 122–126. 2 indexed citations
18.
Sassier, Marion, B. Mennecier, Antoine Coquerel, et al.. (2016). Successful treatment with ceritinib after crizotinib induced hepatitis. Lung Cancer. 95. 15–16. 12 indexed citations
19.
Alexandre, Joachim, Xavier Humbert, Marion Sassier, et al.. (2015). High-Dose Verapamil in Episodic and Chronic Cluster Headaches and Cardiac Adverse Events: Is It as Safe as We Think?. PubMed. 2(1). 13–13. 8 indexed citations
20.
Noal, Sabine, et al.. (2014). Two Cases of Fatal Encephalopathy Related to Ifosfamide: An Adverse Role of Aprepitant. Case Reports in Oncology. 7(3). 669–672. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026